image
Basic Materials - Chemicals - Specialty - NYSE - US
$ 10.78
-0.207 %
$ 1.61 B
Market Cap
21.23
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one CC stock under the worst case scenario is HIDDEN Compared to the current market price of 10.8 USD, The Chemours Company is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one CC stock under the base case scenario is HIDDEN Compared to the current market price of 10.8 USD, The Chemours Company is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one CC stock under the best case scenario is HIDDEN Compared to the current market price of 10.8 USD, The Chemours Company is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CC

image
$22.0$22.0$20.0$20.0$18.0$18.0$16.0$16.0$14.0$14.0$12.0$12.0$10.0$10.0$8.0$8.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
5.78 B REVENUE
-4.07%
457 M OPERATING INCOME
596.74%
86 M NET INCOME
136.13%
-633 M OPERATING CASH FLOW
-113.85%
-353 M INVESTING CASH FLOW
-54.15%
-36 M FINANCING CASH FLOW
-20.93%
1.39 B REVENUE
-7.13%
75 M OPERATING INCOME
-38.52%
-8 M NET INCOME
71.43%
138 M OPERATING CASH FLOW
-0.72%
-107 M INVESTING CASH FLOW
-42.67%
85 M FINANCING CASH FLOW
414.81%
Balance Sheet The Chemours Company
image
Current Assets 3.03 B
Cash & Short-Term Investments 713 M
Receivables 770 M
Other Current Assets 1.54 B
Non-Current Assets 4.49 B
Long-Term Investments 152 M
PP&E 3.44 B
Other Non-Current Assets 896 M
9.49 %10.25 %20.53 %45.79 %11.92 %Total Assets$7.5b
Current Liabilities 1.8 B
Accounts Payable 1.12 B
Short-Term Debt 54 M
Other Current Liabilities 629 M
Non-Current Liabilities 5.11 B
Long-Term Debt 4.25 B
Other Non-Current Liabilities 859 M
16.21 %9.10 %61.48 %12.43 %Total Liabilities$6.9b
EFFICIENCY
Earnings Waterfall The Chemours Company
image
Revenue 5.78 B
Cost Of Revenue 4.63 B
Gross Profit 1.15 B
Operating Expenses 694 M
Operating Income 457 M
Other Expenses 371 M
Net Income 86 M
6b6b5b5b4b4b3b3b2b2b1b1b006b(5b)1b(694m)457m(371m)86mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
19.91% GROSS MARGIN
19.91%
7.90% OPERATING MARGIN
7.90%
1.49% NET MARGIN
1.49%
14.24% ROE
14.24%
1.14% ROA
1.14%
5.37% ROIC
5.37%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis The Chemours Company
image
800m800m600m600m400m400m200m200m00(200m)(200m)(400m)(400m)(600m)(600m)(800m)(800m)(1b)(1b)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 86 M
Depreciation & Amortization 301 M
Capital Expenditures -360 M
Stock-Based Compensation 15 M
Change in Working Capital -1.05 B
Others -999 M
Free Cash Flow -993 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets The Chemours Company
image
Wall Street analysts predict an average 1-year price target for CC of $26.8 , with forecasts ranging from a low of $15 to a high of $32 .
CC Lowest Price Target Wall Street Target
15 USD 39.15%
CC Average Price Target Wall Street Target
26.8 USD 148.92%
CC Highest Price Target Wall Street Target
32 USD 196.85%
Price
Max Price Target
Min Price Target
Average Price Target
35353030252520201515101055Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
1.42% DIVIDEND YIELD
0.0875 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.20001.20001.00001.00000.80000.80000.60000.60000.40000.40000.20000.20000.00000.00000.170.250.250.250.250.250.250.250.170.250.250.250.250.250.250.08750.550.250.250.250.250.250.250.250.640.120.400.251.000.251.000.251.000.251.000.251.000.251.000.250.840.002015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 19
6. Ownership
Insider Ownership The Chemours Company
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
155 K USD 1
9-12 MONTHS
51.9 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
The Chemours Company (CC) Q1 2025 Earnings Call Transcript The Chemours Company (NYSE:CC ) Q1 2025 Results Conference Call May 7, 2025 8:00 AM ET Company Participants Brandon Ontjes - VP, Investor Relations Denise Dignam - President & Chief Executive Officer Shane Hostetter - Chief Financial Officer Conference Call Participants John McNulty - BMO John Roberts - Mizuho Pete Osterland - Truist Laurence Alexander - Research Analyst Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Duffy Fischer - Goldman Sachs Mike Leithead - Barclays Operator Good morning. My name is Michelle, and I will be your conference operator today. seekingalpha.com - 1 week ago
Chemours: Dividend Cut May Signal A Bottom Is Near Chemours has faced significant challenges, including weak demand, excess supply, and poor earnings, leading to a 50% drop in stock value and a 9% after-hours plunge. Despite weak performance, Chemours is nearing a potential buy point due to its free cash flow generation and strategic dividend cut to safeguard its balance sheet. CC expects sequential sales growth and a 40-45% increase in adjusted EBITDA, but the outlook remains cautious due to economic uncertainties and tariffs. seekingalpha.com - 1 week ago
Chemours (CC) Reports Q1 Earnings: What Key Metrics Have to Say The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 1 week ago
Chemours (CC) Q1 Earnings Miss Estimates Chemours (CC) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.32 per share a year ago. zacks.com - 1 week ago
Chemours and Navin Fluorine Announce Agreement to Manufacture New Liquid Cooling Product as a Part of Chemours Expanded Liquid Cooling Venture WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and Navin Fluorine Announce Agreement to Manufacture New Liquid Cooling Product as a Part of Chemours Expanded Liquid Cooling Venture. businesswire.com - 1 week ago
The Chemours Company Reports First Quarter 2025 Results WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports First Quarter 2025 Results. businesswire.com - 1 week ago
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 weeks ago
Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call. businesswire.com - 1 month ago
Chemours price target lowered to $15 from $19 at Mizuho Mizuho analyst John Roberts lowered the firm's price target on Chemours to $15 from $19 and keeps an Outperform rating on the shares. The firm updated price targets in the chemicals, agriculture, and packaging sector to reflect the recent market multiple reductions, and only modestly reduce forward year estimates as Mizuho does not have a recession forecast. However, lower oil prices will reduce the gas-linked cost advantage for many of the basic chemical stocks, the analyst tells investors in a research note. The firm believes March quarter pre-buying for autos and electronics creates "risk for give-back near-term." 22 Apr https://thefly.com - 1 month ago
Why Is Chemours (CC) Down 14% Since Last Earnings Report? Chemours (CC) reported earnings 30 days ago. What's next for the stock? zacks.com - 1 month ago
Chemours Forms Partnership With Energy Fuels to Establish Supply Chain CC & Energy Fuels team up to expand rare earth and critical mineral supply chains in the U.S. domestic market. zacks.com - 2 months ago
Energy Fuels and Chemours Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States DENVER , March 18, 2025 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) and The Chemours Company (NYSE: CC) today announced they are forming a strategic alliance to expand the companies' existing relationship to enhance U.S. domestic rare earth and critical mineral supply chains to meet increasing demand. The alliance will capitalize on the complementary geographic and operational synergies of both organizations. prnewswire.com - 2 months ago
8. Profile Summary

The Chemours Company CC

image
COUNTRY US
INDUSTRY Chemicals - Specialty
MARKET CAP $ 1.61 B
Dividend Yield 1.42%
Description The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Contact 1007 Market Street, Wilmington, DE, 19899 https://www.chemours.com
IPO Date June 19, 2015
Employees 6000
Officers Mr. Shane W. Hostetter CPA Senior Vice President & Chief Financial Officer Mr. Brandon Ontjes Vice President of Investor Relations Ms. Alvenia Scarborough Senior Vice President of Corporate Communications & Chief Brand Officer Mr. Gerardo Familiar Calderon President of Advanced Performance Materials Mr. Aditya Beri Interim President of Titanium Technologies & Chemical Solutions Business Ms. Kristine M. Wellman Senior Vice President, General Counsel & Company Secretary Mr. Brian Shay Interim Chief Human Resources Officer Ms. Denise M. Dignam President, Chief Executive Officer & Director Mr. Joseph T. Martinko President of Thermal & Specialized Solutions Ms. Amber Wellman Ph.D. Chief Sustainability Officer